MedPath

Resolvyx Pharmaceuticals, Inc.

Resolvyx Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2001-01-01
Employees
11
Market Cap
-
Website
http://resolvyx.com

Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-07-17
Last Posted Date
2009-12-02
Lead Sponsor
Resolvyx Pharmaceuticals, Inc
Target Recruit Count
56
Registration Number
NCT00941018
Locations
🇳🇱

PRA International, Zuidlaren, Netherlands

Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

Phase 2
Completed
Conditions
Dry Eye Syndrome
Interventions
Drug: Placebo
First Posted Date
2008-12-01
Last Posted Date
2010-09-24
Lead Sponsor
Resolvyx Pharmaceuticals, Inc
Target Recruit Count
232
Registration Number
NCT00799552
Locations
🇺🇸

ORA Clinical, Andover, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath